Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 7

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 7
---
 ensure that all of the shares you own are represented at the Special Meeting.

Why is our Board of Directors soliciting proxies?

As many of our stockholders may be unable to attend
the Special Meeting virtually, our Board of Directors is soliciting your proxy so that each stockholder is given an opportunity to vote.
The voting methods set forth on the Notice and the proxy enables each stockholder to vote via proxy on all matters that are scheduled
to come before the virtual Special Meeting. When we have timely received votes using the methods set forth on the Notice or a properly
executed proxy card, the stockholder’s shares will be voted at the virtual Special Meeting according to the stockholder’s
directions. We urge stockholders to submit their votes in accordance with the instructions set forth on the Notice received in the mail
or specify their choices by marking the appropriate boxes on the enclosed proxy card, as applicable. If you sign and timely return a proxy
card or otherwise submit your proxy without giving specific instructions, your shares will be voted in accordance with the recommendations
of the Board (“FOR” each of the director nominees named in this Proxy Statement, “FOR” Proposal Nos. 1, 2 and
3, and in the discretion of the proxy holder on any other matters that properly come before the Special Meeting).

| 2 |

When are stockholder proposals and director nominations due for next year’s annual meeting?

Pursuant to Rule 14a-8 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), any stockholder who desires to include a proposal in the Proxy Statement and
form of proxy for our next annual meeting of Stockholders must deliver the proposal in writing to 11555 Sorrento Valley Road, Suite 203,
San Diego, California 92121, Attention: Corporate Secretary, no later than April 18, 2025. Any stockholder proposal submitted outside
the processes of Rule 14a-8 will be considered untimely if delivered to our principal executive offices before May 30, 2025 and after
June 29, 2025. You are also advised to review the Company’s amended and restated bylaws, which contain additional requirements relating
to advance notice of stockholder proposals and director nominations. In addition, stockholders who intend to solicit proxies in support
of director nominees other than the Company’s nominees must also comply with the additional requirements of Rule 14a-19(b). The
timely submission of a